Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and Recruitment

Latent reservoir persistence remains a major obstacle for curing human immunodeficiency virus type 1 (HIV-1) infection. Thus, strategies for the elimination of latent HIV-1 are urgently needed. As a bromodomain and extra-terminal (BET) inhibitor, BMS-986158 has been used in clinical trials for advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xu-Sheng, Tian, Ren-Rong, Ma, Meng-Di, Luo, Rong-Hua, Yang, Liu-Meng, Peng, Guang-Hui, Zhang, Mi, Dong, Xing-Qi, Zheng, Yong-Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952190/
https://www.ncbi.nlm.nih.gov/pubmed/35337136
http://dx.doi.org/10.3390/ph15030338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952190/
https://www.ncbi.nlm.nih.gov/pubmed/35337136
http://dx.doi.org/10.3390/ph15030338

Ejemplares similares